Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rFVIIa in Severely Injured Trauma Subjects
NCT01563523Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2002
- Primary completion
- Oct 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 9
01
Overview
A Phase 2 trial of coagulation factor VIIa in traumatic hemorrhage, sponsored by Novo Nordisk. Started Mar 2002; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
traumatic hemorrhage
Beyond the preview
Go deeper on NCT01563523.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01563523.